| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1600-6143.2011.03784.X |
| P698 | PubMed publication ID | 21992503 |
| P50 | author | Philip F Halloran | Q40000948 |
| Jessica Chang | Q82425822 | ||
| P2093 | author name string | K S Famulski | |
| M Mengel | |||
| B Sis | |||
| G Einecke | |||
| D G de Freitas | |||
| J Sellarés | |||
| L G Hidalgo | |||
| P2860 | cites work | Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. | Q53521493 |
| P433 | issue | 1 | |
| P304 | page(s) | 191-201 | |
| P577 | publication date | 2011-10-12 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | The nature of biopsies with "borderline rejection" and prospects for eliminating this category | |
| P478 | volume | 12 |
| Q91749968 | "Acute kidney dysfunction with no rejection" is associated with poor renal outcomes at 2 years post kidney transplantation |
| Q41946081 | Acute Rejection Phenotypes in the Current Era of Immunosuppression: A Single-Center Analysis |
| Q38186157 | Alemtuzumab and minimization immunotherapy in kidney transplantation: long-term results of comparison with rabbit anti-thymocyte globulin and standard triple maintenance therapy. |
| Q38130585 | Antibody-mediated rejection, T cell-mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies |
| Q35677259 | Antigen-Specific versus Non-Antigen-Specific Immunoadsorption in ABO-Incompatible Renal Transplantation |
| Q38374793 | Chronic Antibody-Mediated Rejection in Nonhuman Primate Renal Allografts: Validation of Human Histological and Molecular Phenotypes. |
| Q36105785 | Decreased Kidney Graft Survival in Low Immunological Risk Patients Showing Inflammation in Normal Protocol Biopsies. |
| Q55430046 | Delayed graft function is associated with an increased rate of renal allograft rejection: A retrospective single center analysis. |
| Q47898148 | Genetics of acute rejection after kidney transplantation. |
| Q89707602 | High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury |
| Q48901557 | Histopathological and clinical findings in renal transplants with Banff type II and III acute cellular rejection without tubulointerstitial infiltrates |
| Q38154130 | Histopathological diagnosis of acute and chronic rejection in pediatric kidney transplantation |
| Q86862867 | Measuring alloreactivity and drug adherence: making the best of what we have |
| Q38154489 | Molecular analysis of transplant rejection: marching onward |
| Q40734481 | Molecular diagnostics identifies risks for graft dysfunction despite borderline histologic changes |
| Q104495338 | Molecular patterns of isolated tubulitis differ from tubulitis with interstitial inflammation in early indication biopsies of kidney allografts |
| Q38773711 | Moving Biomarkers toward Clinical Implementation in Kidney Transplantation |
| Q55311028 | Non-invasive messenger RNA transcriptional evaluation in human kidney allograft dysfunction. |
| Q49724104 | Polyomavirus BK Nephropathy-Associated Transcriptomic Signatures: A Critical Reevaluation |
| Q38067050 | The Banff classification revisited |
| Q36782862 | The Use of Genomics and Pathway Analysis in Our Understanding and Prediction of Clinical Renal Transplant Injury |
| Q43216209 | The impact of early and late acute rejection on graft survival in renal transplantation |
| Q90663092 | Transcriptome Analysis in Renal Transplant Biopsies Not Fulfilling Rejection Criteria |
| Q57014271 | Urinary Metabolomics for Noninvasive Detection of Borderline and Acute T Cell-Mediated Rejection in Children After Kidney Transplantation |
Search more.